Journal of Periodontal and Implant Science

Korean Academy of Periodontology (대한치주과학회)
권호 표지
DOI QR코드

DOI QR Code

Herbal anti-inflammatory immunomodulators as host modulators in chronic periodontitis patients: a randomised, double-blind, placebo-controlled, clinical trial

  • Deore, Girish D. (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre) ;
  • Gurav, Abhijit N. (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre) ;
  • Patil, Rahul (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre) ;
  • Shete, Abhijeet R. (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre) ;
  • Naiktari, Ritam S. (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre) ;
  • Inamdar, Saurabh P. (Department of Periodontology, Tatyasaheb Kore Dental College and Research Centre)
  • Received : 2013.12.24
  • Accepted : 2014.03.25
  • Published : 2014.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Host modulatory therapy has been proposed as a treatment for periodontal diseases. A class of herbal medicines, known to be immunomodulators, alters the activity of immune function through the regulation of informational molecules such as cytokines. In the current study, we tested the hypothesis that herbal immunomodulator drugs act as an adjuvant to scaling and root planing (SRP) in alleviating periodontal inflammation by improving clinical and biochemical parameters. Methods: Sixty healthy subjects (30 in each group) with moderate and severe chronic periodontitis were enrolled in a double-blind, placebo-controlled, double-masked randomised controlled trial. The control group was treated with SRP and a placebo, whereas the test group was treated with SRP followed by dietary supplementation of Septilin for 3 weeks. Periodontal clinical parameters and serum C-reactive protein (CRP) levels were evaluated for all patients at the baseline, 3 weeks, and 6 weeks. Results: Improved gingival index scores found in the test group as compared to the control group were found to be statistically significant only after 3 weeks (P<0.001). In contrast, the decrease in the sulcus bleeding index and pocket depth scores was statistically highly significant in the test group as compared to the control group after 3 weeks and 6 weeks (P<0.001). However, reduced clinical attachment level and CRP scores, as reflected in the test group as compared to the control group, were not found to be statistically significant after both 3 weeks (P>0.05) and 6 weeks (P>0.05). Conclusions: The results of this clinical-biochemical study suggest that dietary supplementation with herbal immunomodulatory agents may be a promising adjunct to SRP and may aid in improving periodontal treatment outcomes.

Keywords

References

  1. Paquette DW, Williams RC. Modulation of host inflammatory mediators as a treatment strategy for periodontal diseases. Periodontol 2000 2000;24:239-52. https://doi.org/10.1034/j.1600-0757.2000.2240112.x
  2. Reddy MS, Geurs NC, Gunsolley JC. Periodontal host modulation with antiproteinase, anti-inflammatory, and bone-sparing agents: a systematic review. Ann Periodontol 2003;8:12-37. https://doi.org/10.1902/annals.2003.8.1.12
  3. Bhatavadekar NB, Williams RC. New directions in host modulation for the management of periodontal disease. J Clin Periodontol 2009;36:124-6. https://doi.org/10.1111/j.1600-051X.2008.01354.x
  4. Salvi GE, Lang NP. Host response modulation in the management of periodontal diseases. J Clin Periodontol 2005;32 Suppl 6:108-29. https://doi.org/10.1111/j.1600-051X.2005.00785.x
  5. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Health Organ 2000;78:252-7.
  6. Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev 2006;11:128-50.
  7. Kim MS, Yi JM, Kim SH, Hong SH, Kim HM. Madimadi, Korean folk medicine, blocks TNF-alpha, IL-1beta, and IL-8 production by activated human immune cells. Cytokine 2004;25:179-86. https://doi.org/10.1016/j.cyto.2003.11.016
  8. Plaeger SF. Clinical immunology and traditional herbal medicines. Clin Diagn Lab Immunol 2003;10:337-8.
  9. Udupa AL, Rao SG, Kulkarni DR. Wound healing profile of Septilin. Indian J Physiol Pharmacol 1989;33:39-42.
  10. Praveenkumar V, Kuttan R, Kuttan G. Immunopotentiating activity of septilin. Indian J Exp Biol 1997;35:1319-23.
  11. Daswani BR, Yegnanarayan R. Immunomodulatory activity of septilin, a polyherbal preparation. Phytother Res 2002;16:162-5. https://doi.org/10.1002/ptr.996
  12. Meropol SB, Chan KA, Chen Z, Finkelstein JA, Hennessy S, Lautenbach E, et al. Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf 2008;17:523-32. https://doi.org/10.1002/pds.1547
  13. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-90. https://doi.org/10.1111/j.1600-051X.2007.01173.x
  14. Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragao Farias NS, et al. Chronic periodontitis and C-reactive protein levels. J Periodontol 2011;82:969-78. https://doi.org/10.1902/jop.2010.100511
  15. Varma RS, Ashok G, Vidyashankar S, Patki P, Nandakumar KS. Anti-inflammatory properties of Septilin in lipopolysaccharide activated monocytes and macrophage. Immunopharmacol Immunotoxicol 2011;33:55-63. https://doi.org/10.3109/08923971003739236
  16. Page RC, Eke PI. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007;78(7 Suppl): 1387-99. https://doi.org/10.1902/jop.2007.060264
  17. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg 2012;10:28-55. https://doi.org/10.1016/j.ijsu.2011.10.001
  18. Moore CP. Immunomodulating agents. Vet Clin North Am Small Anim Pract 2004;34:725-37. https://doi.org/10.1016/j.cvsm.2004.01.002
  19. Gani DK, Lakshmi D, Krishnan R, Emmadi P. Evaluation of C-reactive protein and interleukin-6 in the peripheral blood of patients with chronic periodontitis. J Indian Soc Periodontol 2009;13:69-74. https://doi.org/10.4103/0972-124X.55840
  20. Ide M, McPartlin D, Coward PY, Crook M, Lumb P, Wilson RF. Effect of treatment of chronic periodontitis on levels of serum markers of acute-phase inflammatory and vascular responses. J Clin Periodontol 2003;30:334-40. https://doi.org/10.1034/j.1600-051X.2003.00282.x
  21. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79:49-57. https://doi.org/10.1177/00220345000790010701
  22. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders? J Hypertens 2003;21:1787-803. https://doi.org/10.1097/00004872-200310000-00002
  23. Soeken KL, Miller SA, Ernst E. Herbal medicines for the treatment of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2003;42:652-9. https://doi.org/10.1093/rheumatology/keg183
  24. Sharma SB, Ray S. Effect of herbal preparation on immune response of immunosuppressed mice. Indian J Physiol Pharmacol 1997;41:293-6.
  25. Grewal DS, Sharma BK, Shah DD, Sheode JH. Septilin and geriforte in allergic and vasomotor rhinitis. Auris Nasus Larynx 1985;12:95-101. https://doi.org/10.1016/S0385-8146(85)80006-7
  26. Khanna N, Sharma SB. Anti-inflammatory and analgesic effect of herbal preparation: septilin. Indian J Med Sci 2001;55:195-202.
  27. Shetty S, Bose A, Sridharan S, Satyanarayana A, Rahul A. A clinico-biochemical evaluation of the role of a herbal (Ayurvedic) immunomodulator in chronic periodontal disease: a pilot study. Oral Health Dent Manag 2013;12:95-104.
  28. Ju HK, Baek SH, An RB, Bae K, Son KH, Kim HP, et al. Inhibitory effects of nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis factor-alpha production in lipopolysaccharide activated macrophages. Biol Pharm Bull 2003;26:1375-8. https://doi.org/10.1248/bpb.26.1375
  29. Van Dyke TE, Lester MA, Shapira L. The role of the host response in periodontal disease progression: implications for future treatment strategies. J Periodontol 1993;64(8 Suppl):792-806. https://doi.org/10.1902/jop.1993.64.8s.792
  30. Howell TH, Fiorellini J, Weber HP, Williams RC. Effect of the NSAID piroxicam, topically administered, on the development of gingivitis in beagle dogs. J Periodontal Res 1991;26(3 Pt 1):180-3. https://doi.org/10.1111/j.1600-0765.1991.tb01643.x
  31. Abernethy TJ, Avery OT. The occurrence during acute infections of a protein not normally present in the blood: I. Distribution of the reactive protein in patients' sera and the effect of calcium on the flocculation reaction with c polysaccharide of pneumococcus. J Exp Med 1941;73:173-82. https://doi.org/10.1084/jem.73.2.173
  32. Hedlund P. Clinical and experimental studies on C-reactive protein (acute phase protein). Acta Med Scand Suppl 1961;361:1-71.
  33. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med 1930;52:561-71. https://doi.org/10.1084/jem.52.4.561
  34. Perlman E, Bullowa JG, Goodkind R. An immunological and electrophoretic comparison of the antibody to c polysaccharide and the C-reactive protein of acute phase serum. J Exp Med 1943;77:97-110. https://doi.org/10.1084/jem.77.2.97
  35. Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V, et al. Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2002;2:30. https://doi.org/10.1186/1471-2334-2-30
  36. Iwamoto Y, Nishimura F, Soga Y, Takeuchi K, Kurihara M, Takashiba S, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adiponectin levels in patients with chronic periodontitis. J Periodontol 2003;74:1231-6. https://doi.org/10.1902/jop.2003.74.8.1231
  37. D'Aiuto F, Parkar M, Andreou G, Brett PM, Ready D, Tonetti MS. Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol 2004;31:402-11. https://doi.org/10.1111/j.1600-051X.2004.00580.x
  38. D'Aiuto F, Ready D, Tonetti MS. Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 2004;39:236-41. https://doi.org/10.1111/j.1600-0765.2004.00731.x
  39. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-73. https://doi.org/10.1177/154405910508400312
  40. Montebugnoli L, Servidio D, Miaton RA, Prati C, Tricoci P, Melloni C, et al. Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease. J Clin Periodontol 2005;32:188-92. https://doi.org/10.1111/j.1600-051X.2005.00641.x

Cited by

  1. Nutrition as Adjunct Therapy in Periodontal Disease Management vol.6, pp.2, 2014, https://doi.org/10.1007/s40496-019-0216-4
  2. Research possibility of using an enzymatic hydrolyzate of the lymphoid tissue of broiler chickens as an immunomodulator vol.38, pp.None, 2021, https://doi.org/10.1016/j.bcab.2021.102214